首页|骨质疏松症中联合和序贯治疗的进展

骨质疏松症中联合和序贯治疗的进展

扫码查看
骨质疏松症是一种常见的系统性退行性疾病,对中国的国民健康构成了重大挑战,尤其会引起骨折等并发症.骨质疏松症的治疗干预主要包括骨吸收抑制剂和骨形成促进剂.许多研究强调了使用不同药物类型的序贯和联合治疗的重要性.这些方法在增加骨密度、降低骨折风险和预防骨质疏松症进展方面显示出显著的疗效.本文旨在整合各种序贯治疗方案,为临床医生在实践中提供有价值的见解.
Advancements in sequential and combination treatments for osteoporosis
Osteoporosis,a prevalent systemic degenerative disease,poses significant challenges to China's national health,particularly due to complications such as fractures.Therapeutic interventions for osteoporosis primarily involve bone resorption inhibitors(antiresorptive)and bone formation promoters(anabolic).Numerous studies underscore the importance of sequential and combination treatments using diverse drug types.Such approaches have shown considerable efficacy in increasing bone mineral density,reducing fracture risk,and preventing the progression of osteoporosis.This article aimed to consolidate various sequential treatment schemes,offering valuable insights for clinicians in their practice.

OsteoporosisSequential treatmentCombination treatment

郑佳、付颖

展开 >

首都医科大学附属北京潞河医院,北京 101149

首都医科大学附属北京潞河医院内分泌代谢与免疫性疾病中心,北京 101149

糖尿病防治研究北京市重点实验室,北京 101149

骨质疏松症 序贯治疗 联合治疗

2024

中国药学(英文版)
中国药学会

中国药学(英文版)

CSTPCD
影响因子:0.534
ISSN:1003-1057
年,卷(期):2024.33(7)